Secondly, the incidence of bleeding was 4 9 % amongst which seven fatal cerebral haemorrhages occurred.
However, neither the incidence of spontaneous disobliteration nor the optimal dose and duration of SK therapy have yet been established. Furthermore, no controlled and randomized study is available comparing in this condition the value of SK treatment to other current therapeutic regimens.
Since the introduction of Fogarty's catheter (Fogarty, Cranley, Krause, Strasser, and Hafner, 1963) After this coumarin therapy was continued to maintain the prothrombin time between 20 and 25 %.
The response to treatment was followed by daily oscillography and daily clinical examination; arteriography was repeated four to six days after streptokinase therapy was stopped.
All patients were checked biweekly in our outpatient clinic after release from the hospital.
Results
The results of therapy are summarized in Table I .
Of the 11 patients with pelvic arterial occlusions, six gave definite signs of resolution after streptokinase therapy. One of the six also had evidence of marked improvement in femoral artery flow on the both sides after streptokinase therapy. There were 74 femoral artery occlusions in 57 patients. In 24, flow was restored after streptokinase therapy. In three other cases a complete obstruction was partly relieved to reveal a severe stenotic lesion. Out of nine patients with 13 femoral artery stenoses, flow was restored completely in seven, whereas in five others it remained unchanged, and in one complete obliteration occurred.
The seven successfully treated peripheral arterial occlusions may be attributed to the short duration of the occlusions. That is to say, none of the occlusions was more than 14 days old. The most recent was seven days old. All of the occlusions which had existed for more than 14 days were resistant to therapy.
All the patients who responded favourably in therapy had had an exacerbation of symptoms within the last four months before therapy was begun, and was responsible in most patients for the hospital admission. None of the patients who had longstanding clinical symptoms of arterial occlusion without any recent acute episode gave evidence of 643 resolution on arteriography after streptokinase therapy.
All patients with evidence of improvement on arteriography also showed considerable clinical improvement and a marked increase in the distance that they could walk without claudication. During streptokinase therapy many patients volunteered the information that there was improvement in the coldness and numbness of their limbs and some reported an increase in the distance that they could walk without claudication from 50 to 1 500 yards. This improvement occurred even in patients in whom repeat angiography demonstrated no improvement. 
